Navigation Links
Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors
Date:10/15/2007

and the product portfolio."

Frutarom will act to extract the greatest advantage from the operational synergy between its activities and the Gewurzmuller Group's activities in Germany and elsewhere in order to achieve optimal operational efficiency and savings.

Yehudai concluded by saying, "Frutarom will continue to implement its rapid growth strategy. The acquisition of the Gewurzmuller group is Frutarom's sixth so far this year. Frutarom continuously seeks additional strategic acquisitions of companies and activities in its field."

Background on the Company

Frutarom is a global company with significant production and development centers on three continents that markets its products on five continents to over 5,000 customers in more than 120 countries. Frutarom's products are intended mainly for the food, beverage, flavor, fragrance, pharmaceutical, nutraceutical, health food, functional food, food additive, and cosmetic industries.

Frutarom operates through two Divisions:

- The Flavors Division, which develops, produces and markets flavor compounds and food systems.

- The Fine Ingredients Division, which develops, produces and markets natural flavor extracts, natural functional food ingredients, natural pharmaceutical/nutraceutical extracts, specialty essential oils and citrus products, and aroma chemicals.

Frutarom's products are produced at its plants in the United States, England, Switzerland, Germany, Israel, Denmark, China, and Turkey. The Company's global marketing organization includes branches in Israel, the United States, England, Switzerland, Germany, Belgium, Holland, Denmark, France, Hungary, Romania, Russia, Ukraine, Kazakhstan, Belarus, Turkey, Brazil, Mexico, China, Japan, Hong Kong, India and Indonesia. The Company also works through local agents and distributors worldwide. Frutarom has about 1,300 employees worldwide.

For further information, visit our website: '/>"/>

SOURCE Frutarom Industries Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Wockhardt acquires Protinex, Farex brands from Netherland Co
6. Indoco Remedies Acquires La Nova Chem
7. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
8. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
9. Apollos Global Arm Acquires US-based Firm
10. ‘Obesity’ Acquires Permanent Resident Status in the US
11. Indias Wockhardt Acquires Irish Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... A cleanroom manufacturing company has ...eanrooms. The feature is a utility panel which ca...nce the cleanroom appearance. , ...Gerbig Engineering, a designer, fabricator and ins...they are now offering a utility panel for integrat...
(Date:7/23/2008)...und,s Commitment to Meet the Financing Needs of Eu...and Institutions--, NEW YORK, July 24 /PRNewswire...n Macleod, Ph.D., has been promoted to Partner. Ba...s responsible for sourcing,evaluating and negotia...rtunities for the Paul Capital Healthcare funds., ...
(Date:7/23/2008)...M, N.C. A study out of Wake Forest University Bap...ctors are correctly identifying patients who are h...aven,t yet confirmed it. , The study used data f...ts with heart attack symptoms who were admitted to...g U.S. centers. , The findings were released to...
(Date:7/23/2008)...d Problem For 10+ Years Even Though Some Kilns Emi...n Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, ...wire-USNewswire/ -- For more than a decade,after C...n from cement,kilns across the nation, the U.S. En...e action. Now, a new study from Earthjustice and t...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
... Health Organization estimates that 40 million peo.../of them in developing countries. In some African ...irus. Last year, an estimated 700,000 children cau...the risk is greatest, researchers have settled on ...
Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
...ncer survivors can now get up and get moving. Brea... older women, reported higher body esteem and bett...a new study. Researchers compared 40 women who sa...ary women, all early-stage breast cancer survivors...
... took the most antibiotics , or who took the drugs... // developing breast cancer over an average of ab...he drugs, the study showed. Also, since antibiotic...common infections caused by bacteria, some pneumon...
Other Medicine News:Health News:Drug to stop HIV spread to babies may Indirectly harm The Mother 2
(Date:7/23/2008)..., July 23 /- Sound Pharmaceuticals (S...ion with the FDA for the clinical,testing of a pro... of,chemotherapy induced hearing loss or ototoxici... will be tested in advanced stage lung cancer,and ...ased chemotherapy.,This marks the second developme...
(Date:7/23/2008)..., July 23 /- Dendreon Corpo...pects the Independent Data,Monitoring Committee (I...s,of overall survival relating to the Company,s Ph...inoma Treatment, also known as D9902B) clinical tr... Company,s investigational,active cellular immunot...
(Date:7/22/2008)...awards under Therapeutics Development Initiative b... to 23; next deadline January 20,2009, NEW YORK,... mission to,speed delivery of transformative treat...ael J. Fox Foundation for Parkinson,s Research has...stry research teams. The awards,were granted under...
(Date:7/22/2008)...frey Allan Will Stress the Importance to Patients ...Approval Pathway, RICHMOND, Va., July 22 /PRNewsw...developer of follow-on biologics and biopharmaceut... CEO of Insmed, will present at a,Congressional br...ignificant need for establishing an approval pathw...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4Interferon does not slow or stop hepatitis C from worsening study finds 5962 1Interferon does not slow or stop hepatitis C from worsening study finds 5962 2UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2Pill Poses Little Cervical Cancer Risk 5956 1Pill Poses Little Cervical Cancer Risk 5956 2Pill Poses Little Cervical Cancer Risk 5956 3
...Survival Benefit in,Liver Cancer -, CHICAGO, June ...e Pharmaceuticals Inc. and Onyx Pharmaceuticals, I...blets significantly,extended overall survival in p...imary liver cancer versus those taking placebo by ...ted at the 43rd,annual meeting of the American Soc...
... - Researchers at,Molecular Insight Pharmaceutical...data on MIP-1072, a radiolabeled, small molecule,m... diagnosis and,staging of prostate cancer at the 5...ine (SNM) in Washington, D.C. MIP-1072 is,one of t...nosis,that Molecular Insight plans to advance into...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4
...rocleix System has added a significant layer of a ...nnovative technologies developed by Gen-Probe incl...plification technique called Transcription-Mediate...ay can simultaneously detect the presence of HIV-1...
...Antibody Test (Reveal Test) is MedMiras flagship r...an serum or plasma against HIV-1 that are produced...eal Test is based on MedMiras proprietary flow-thr...ngle-use test cartridge containing an immunoreacti...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple
X-Hair Trephines
Medicine Products: